Readoutin 14d
Teva Branded Pharmaceutical Products R&D LLC — TEV-56248
Phase 3 primary completion: A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations.
- Date
- Dec 2026
- Type
- Readout
- Indication
- Asthma